Sphingosine-1-Phosphate Metabolic Pathway in Cancer: Implications for Therapeutic Targets
International Journal of Molecular Sciences · 26.01.2025 · 26 (3) · 1056
DOI: 10.3390/ijms26031056 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.01.2025. Verfasst von Miguel L Rufail und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Virginia Commonwealth University, Richmond, VA 23298, USA. Hauptthemen laut MEDLINE: Lysophospholipids, Sphingosine, Neoplasms, Metabolic Networks and Pathways. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Piano di sostegno alla ricerca BIOMETRA-Linea B, Piano di sostegno alla ricerca BIOMETRA–Linea B.
Abstract (Originalsprache)
Cancer biology revolves around understanding how cells undergo uncontrolled proliferation leading to the formation of malignant tumors. Key aspects include self-sufficiency in growth signals, the lack of response to signals of growth inhibition, the evasion of apoptosis, sustained angiogenesis, the evasion of immune response, the capacity to invade and metastasize, and alterations in cellular metabolism. A vast amount of research, which is exponentially growing, over the past few decades highlights the role of sphingolipids in cancer. They act not only as structural membrane components but also as bioactive molecules that regulate cell fate in different physio-pathological conditions. In cancer, sphingolipid metabolism is dysregulated, contributing to tumor progression, metastasis, and drug resistance. In this review, we outline the impact of sphingosine-1-phosphate (S1P) as a key bioactive sphingolipid in cancer. We give an overview of its metabolism summarizing the role of S1P as an intracellular and extracellular mediator through specific plasma membrane receptors in different cancers. We also describe previous findings on how the disruption in the balance between S1P and ceramide (Cer) is common in cancer cells and can contribute to tumorigenesis and resistance to chemotherapy. We finally consider the potential of targeting the metabolic pathways of S1P as well as its receptors and transporters as a promising therapeutic approach in cancer treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Virginia Commonwealth University, Richmond, VA 23298, USA.
- Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, LITA Segrate, Via Fratelli Cervi, 93, 20054 Segrate, Italy.
ORCID-Profile: Paola Giussani
Förderung
- Piano di sostegno alla ricerca BIOMETRA-Linea B
- Piano di sostegno alla ricerca BIOMETRA–Linea B
Zitieren
APA
Rufail, M. L., Bassi, R., & Giussani, P. (2025). Sphingosine-1-Phosphate Metabolic Pathway in Cancer: Implications for Therapeutic Targets. International Journal of Molecular Sciences, 26(3), 1056. https://doi.org/10.3390/ijms26031056
Vancouver
Rufail ML, Bassi R, Giussani P. Sphingosine-1-Phosphate Metabolic Pathway in Cancer: Implications for Therapeutic Targets. International Journal of Molecular Sciences. 2025;26(3):1056. doi:10.3390/ijms26031056
BibTeX
@article{Rufail2025,
author = {Rufail, Miguel L and Bassi, Rosaria and Giussani, Paola},
title = {Sphingosine-1-Phosphate Metabolic Pathway in Cancer: Implications for Therapeutic Targets},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {3},
pages = {1056},
doi = {10.3390/ijms26031056}
}
EUVIMED